Omega-3 fatty acids, acute coronary syndrome, and sudden death

William S. Harris, Clemens von Schacky

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Omega-3 fatty acids (FAs) are currently recommended to reduce the risk of cardiovascular diseases. These recommendations are based on randomized trials, prospective cohort studies, and case-control data and are supported by experimental studies in humans, animals, and isolated cells. Raising tissue levels of omega-3 FAs reduces the risk of sudden cardiac death, most likely due to reduced susceptibility to fatal arrhythmias, but the effect of these FAs on the risk of myocardial infarction per se is less clear. Reductions in nonfatal events have not typically been seen in randomized trials, but case-control and prospective cohort studies support such an effect. Future studies should assess tissue levels of omega-3 FAs to more precisely estimate exposure and to more clearly define the relations between omega-3 status and the risk of fatal or nonfatal cardiovascular diseases.

Original languageEnglish (US)
Pages (from-to)161-166
Number of pages6
JournalCurrent Cardiovascular Risk Reports
Volume2
Issue number2
DOIs
StatePublished - Dec 1 2008

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Omega-3 fatty acids, acute coronary syndrome, and sudden death'. Together they form a unique fingerprint.

Cite this